Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J ROBERT

Showing results (1061-1070 of 1,768) with videos related to

Pageof 177
Sort By:
AJNR. American Journal of Neuroradiology|March 1, 1994
Technical feasibility and performance studies of a Doppler guide wire for potential neuroendovascular applicationsJ C Chaloupka, F Viñuela, R P Malanum, et al.
Presse Medicale (Paris, France : 1983)|November 20, 2001
[Obesity in children and adolescents, mental disorders and familial psychopathology]E Zipper, G Vila, M Dabbas, et al.
Journal of Physiology, Paris|January 1, 1993
Tyrosine hydroxylase regulation in neurotransmission and neuroplasticityC Icard-Liepkalns, S Berrard, N Faucon Biguet, et al.
The Journal of Biological Chemistry|February 12, 2010
Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residuesVeli-Pekka Jaakola, J Robert Lane, Judy Y Lin, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligibleBrian L Egleston, Omar Pedraza, Yu-Ning Wong, et al.
Progress in Neurological Surgery|July 11, 2018
Gene Therapy and Virotherapy of GliomasJulius W Kim, Alan L Chang, J Robert Kane, et al.
Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D<sub>2</sub> ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 28, 2006
[Thyroiditis and gluten intolerance: extrapancreatic auto-immune diseases associated with type 1 diabetes]S Faesch, F Jennane, I Izembart, et al.
Journal of Medical Genetics|September 15, 2006
Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: new hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical regionC Diatloff-Zito, A Nicole, G Marcelin, et al.
Anesthesiology|January 7, 2012
First human administration of MR04A3: a novel water-soluble nonbenzodiazepine sedativeJ Robert Sneyd, Ann E Rigby-Jones, Maurice Cross, et al.
Pageof 177

Showing results (1061-1070 of 1,768) with videos related to

Sort By:
Pageof 177
AJNR. American Journal of Neuroradiology|March 1, 1994
Technical feasibility and performance studies of a Doppler guide wire for potential neuroendovascular applicationsJ C Chaloupka, F Viñuela, R P Malanum, et al.
Presse Medicale (Paris, France : 1983)|November 20, 2001
[Obesity in children and adolescents, mental disorders and familial psychopathology]E Zipper, G Vila, M Dabbas, et al.
Journal of Physiology, Paris|January 1, 1993
Tyrosine hydroxylase regulation in neurotransmission and neuroplasticityC Icard-Liepkalns, S Berrard, N Faucon Biguet, et al.
The Journal of Biological Chemistry|February 12, 2010
Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residuesVeli-Pekka Jaakola, J Robert Lane, Judy Y Lin, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligibleBrian L Egleston, Omar Pedraza, Yu-Ning Wong, et al.
Progress in Neurological Surgery|July 11, 2018
Gene Therapy and Virotherapy of GliomasJulius W Kim, Alan L Chang, J Robert Kane, et al.
Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D<sub>2</sub> ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 28, 2006
[Thyroiditis and gluten intolerance: extrapancreatic auto-immune diseases associated with type 1 diabetes]S Faesch, F Jennane, I Izembart, et al.
Journal of Medical Genetics|September 15, 2006
Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: new hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical regionC Diatloff-Zito, A Nicole, G Marcelin, et al.
Anesthesiology|January 7, 2012
First human administration of MR04A3: a novel water-soluble nonbenzodiazepine sedativeJ Robert Sneyd, Ann E Rigby-Jones, Maurice Cross, et al.
Pageof 177